Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

92 CARBAMAZEPINE
Exfoliative dermatitis
(2001): Dintiman B, Fairfax, VA (from Internet) (observation)
(1999): Lombardi SM+, Ann Pharmacother 33, 571
(1996): Sigurdsson V+, JAmAcadDermatol35, 53
(1996): Troost RJ+, Pediatr Dermatol 13, 316
(1995): Bahamdan KA+, Int J Dermatol 34, 661
(1995): Corazza M+, Contact Dermatitis 33, 447
(1995): Koga T+, Contact Dermatitis 32, 181
(1993): Alanko K, Contact Dermatitis 29, 254
(1991): Blin O+, Therapie (French) 46, 91
(1990): Gebauer K+, Australas J Dermatol 31, 89 (passim)
(1989): Alanko K+, Acta Derm Venereol (Stockh) 69, 223
(1989): Romaguera C+, Contact Dermatitis 20, 304
(1989): Vaillant L+, Arch Dermatol 125, 299
(1988): Cox NH+, Postgrad Med J 64, 249
(1987): Gimenez Garcia RM+, Rev Clin Esp (Spanish) 181, 542
(1987): Granier F+, Rev Med Interne 8, 206
(1985): Camarasa JG, Contact Dermatitis 12, 49
(1984): Shuttleworth D+, Clin Exp Dermatol 9, 421
(1982): Reed MD+, Clin Pharm 1, 78
(1981): Roberts DL+, Arch Dermatol 117, 273
Facial edema
(2002): Kansky A+, Acta Dermatoven 11(3), 105
Fixed eruption (